The United Kingdom’s HealthTech and MedTech sectors are navigating a structural transition. Following a multi-year period of post-pandemic valuation compression, capital scarcity, and constrained public market activity between 2023 and 2025, the market is demonstrating signs of strategic acceleration and operational evolution. The state is increasingly acting as a primary market-maker. The convergence of the National Health Service (NHS) 10 Year Health Plan, the Medicines